Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors-Reference-Cited by-同舟云学术

Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors

Published:2013-04-22 Issue:9 Volume:14 Page:1111-1118
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Masuda Kiyomi,Aoki Kazutaka,Kamiko Kazunari,Takihata Masahiro,Ito Yuzuru,Nagakura Mieko,Kawasaki Satsuki,Akema Noriko,Hasegawa Maki,Nakajima Shigeru,Shinoda Kazuaki,Toumura Shyoken,Tsunoda Seishi,Enomoto Hitoshi,Shimotomai Hidefumi,Terauchi Yasuo

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2013.790365

Reference24 articles.

1. Oral antidiabetic agents as cardiovascular drugs

2. Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus

3. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance

4. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

5. Divided-Dose Administration of Miglitol just before and 15 Minutes after the Start of a Meal Smoothes Postprandial Plasma Glucose Excursions and Serum Insulin Responses in Healthy Men

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study;Diabetes & Metabolism Journal;2019

2. Incretin enhancement without hyperinsulinemia: α-glucosidase inhibitors;Expert Review of Endocrinology & Metabolism;2014-06-25

3. Alogliptin benzoate for the treatment of type 2 diabetes;Expert Opinion on Pharmacotherapy;2014-03-19

4. Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin;Endocrine Journal;2014

5. Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels;Endocrine Journal;2014